Global Allergy Diagnostics and Therapeutics Market
From GlobeNewswire: 2024-11-18 12:30:00
The global Allergy Diagnostics and Therapeutics Market is projected to reach around USD 78,036.1 Million by 2033, with a compound annual growth rate (CAGR) of about 8.1%. Factors driving market growth include rising allergic conditions, advancements in diagnostic technologies, demand for personalized medicine, increasing healthcare expenditure, expanding allergen exposure, and regulatory support.
In 2023, Astria Therapeutics, Inc. announced a license agreement with Inchon’s Sciences to advance STAR-0310 for potential treatments targeting atopic dermatitis and other allergic conditions. Allergy Partners collaborated with Aimmune Therapeutics to provide PALFORZIA for peanut allergy treatment. Oncologica introduced a novel Allergy Focus Test to help individuals manage allergies effectively.
The report on the Allergy Diagnostics and Therapeutics Market covers market size data, growth factors, dynamics, and recent trends. The market was valued at approximately USD 35,812.8 Million in 2023, with a projected market size of USD 38,713.6 Million in 2024. Key segments include Product Type, Test Type, Allergen Type, End User, and Region. Regional scope covers North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The Allergy Diagnostics and Therapeutics Market report for 2024 provides an in-depth industry analysis, including the impact of the COVID-19 pandemic. Disruption in healthcare services, patient priority shifts, and the adoption of telehealth were key impacts. As the industry recovers, there is a focus on patient safety protocols and government support. Regional analysis shows segmentation across North America, Europe, Asia-Pacific, and LAMEA, reflecting market trends and opportunities. For more information and a customized copy of the report, visit the link provided. North America leads in allergy diagnostics and therapeutics with advanced healthcare infrastructure and high allergy prevalence. Europe focuses on standardized allergy management and advancements in allergen-specific immunotherapy. Asia-Pacific experiences rapid market growth due to rising allergy incidence. The LAMEA region sees growing awareness and adoption of allergy diagnostics and therapeutics. Major players in the market include Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Danaher Corporation. For more information, visit the link provided for a comprehensive report on the Allergy Diagnostics and Therapeutics Market. Benefit from spectacular deals such as maximum market coverage, subscription-based options, and free customization. 1. Scientists have discovered a new species of dinosaur in Argentina, named Llukalkan aliocranianus. The carnivorous dinosaur had a unique skull structure with air pockets and large teeth, indicating it was a formidable predator. This new discovery sheds light on the diversity of dinosaurs during the Late Cretaceous period.
2. A study published in the journal Nature Climate Change reveals that the melting of glaciers in Greenland and Antarctica is accelerating faster than previously thought. The study estimates that the ice loss from these regions has contributed to a sea-level rise of 0.7 inches since 1993, posing a threat to coastal communities worldwide.
3. The World Health Organization (WHO) has declared the Ebola outbreak in Guinea officially over. The outbreak began in February and claimed the lives of 12 people. WHO praised the swift response of health authorities in containing the outbreak and emphasized the importance of maintaining vigilance against future outbreaks of the deadly virus. 1. The stock market saw a sharp decline today, with the Dow Jones Industrial Average dropping 500 points. This was attributed to fears of a global economic slowdown due to the ongoing trade war between the US and China.
2. A new study published in a medical journal found that eating a diet high in processed foods can increase the risk of developing cancer. The study followed over 100,000 participants and found a significant link between processed food consumption and cancer rates.
3. In a groundbreaking discovery, scientists have identified a new species of dinosaur in Argentina. The newly discovered dinosaur, named Lavocatisaurus agrioensis, is believed to have lived over 110 million years ago and provides new insights into the evolution of dinosaurs in South America.
4. The United Nations released a report stating that over 100,000 civilians have been killed or injured in Afghanistan over the past decade. The report highlighted the ongoing violence and instability in the region, calling for increased efforts to protect civilians and promote peace. 1. In a groundbreaking study, researchers have discovered a new species of dinosaur in Argentina. The species, named Llukalkan aliocranianus, is believed to have roamed the Earth during the Late Cretaceous period. This finding sheds new light on the diversity of dinosaurs that existed millions of years ago.
2. The United States has surpassed a grim milestone of 500,000 confirmed COVID-19 deaths. This tragic figure highlights the devastating impact of the pandemic on the country. Health officials continue to urge the public to adhere to safety measures such as wearing masks and practicing social distancing to curb the spread of the virus.
3. Tesla CEO Elon Musk has announced plans to build a new Gigafactory in Texas. The factory, which will produce the Cybertruck and Model Y vehicles, is expected to create thousands of jobs and boost the local economy. This move underscores Tesla’s commitment to expanding its production capacity and meeting growing demand for electric vehicles.
4. The European Union has approved the use of the AstraZeneca-Oxford COVID-19 vaccine, following a thorough review of its safety and efficacy. The vaccine has been shown to be effective in preventing severe illness and reducing transmission of the virus. This approval will help accelerate vaccination efforts across the EU and combat the spread of COVID-19.
Read more at GlobeNewswire: Global Allergy Diagnostics and Therapeutics Market